NHS SCOTLAND
Providing advice about the status of all newly licensed medicines
The SMC has 3 public partners. These are members of the general public who offer a wider perspective to the assessment process.
Patients, carers and the general public are also represented through submissions of evidence from Patient Interest Groups. To help Patient Interest Groups with their submissions the pharmaceutical company may prepare a Summary of Information for Patients.
More information about Patient Interest Groups and what is required in their submissions is available in the Making Your Voice Heard section.